Cadrenal Therapeutics, Inc. Common Stock (CVKD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.39M
Last updated: Nov 17, 2026 at 11:02 AM ET
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Earnings: Report Dates and Results
Cadrenal Therapeutics, Inc. Common Stock (CVKD) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Cadrenal Therapeutics, Inc. Common Stock reported EPS of -$1.14, above the -$1.16 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CVKD has an expected report date of Mar 29, 2027.
Earnings History
Of the 10 quarters below that had an estimate, CVKD beat 4 and missed 6. The widest gap in the table came in the quarter ended Dec 31, 2023, when EPS landed 37.50% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$1.14 | -$1.16 | N/A | +1.72% | Beat | N/A | 1 | 0 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$1.04 | -$1.57 | -$1.86 - -$1.29 | +33.76% | Beat | N/A | 2 | 0 up, 0 down | May 7, 2026 |
| Dec 31, 2025 | -$1.41 | -$1.21 | -$1.21 - -$1.21 | -16.53% | Miss | N/A | 1 | 0 up, 0 down | Mar 31, 2026 |
| Sep 30, 2025 | -$1.31 | -$1.55 | -$1.55 - -$1.55 | +15.48% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2025 |
| Jun 30, 2025 | -$1.87 | -$1.77 | -$2.07 - -$1.48 | -5.65% | Miss | N/A | 2 | 0 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$2.09 | -$1.64 | N/A | -27.44% | Miss | N/A | 1 | 0 up, 0 down | May 8, 2025 |
| Dec 31, 2024 | -$2.55 | -$0.15 | N/A | N/A | N/A | N/A | 2 | 0 up, 1 down | Mar 13, 2025 |
| Sep 30, 2024 | -$2.18 | -$1.80 | -$2.40 - -$1.20 | -21.11% | Miss | N/A | 3 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$2.25 | -$1.80 | -$1.80 - -$0.75 | -25.00% | Miss | N/A | 2 | 0 up, 0 down | Aug 7, 2024 |
| Mar 31, 2024 | -$1.50 | -$1.35 | -$1.35 - -$0.75 | -11.11% | Miss | N/A | 2 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.05 | -$0.08 | -$0.09 - -$0.08 | +37.50% | Beat | N/A | 2 | 0 up, 0 down | Mar 11, 2024 |
| Sep 30, 2023 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2023 |
| Jun 30, 2023 | -$1.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 10, 2023 |
| Mar 31, 2023 | -$6.62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2023 |
| Dec 31, 2022 | -$0.85 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2023 |
| Jun 30, 2022 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 22, 2022 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$6.68, after -$8.48 the year before. It was -$0.91 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$6.68 | N/A |
| Dec 31, 2024 | -$8.48 | N/A |
| Dec 31, 2023 | -$8.10 | N/A |
| Dec 31, 2022 | -$0.91 | N/A |
Frequently Asked Questions About CVKD
When is Cadrenal Therapeutics, Inc. Common Stock's next earnings date?
Cadrenal Therapeutics, Inc. Common Stock's next earnings report is expected for Mar 29, 2027.
Did CVKD beat earnings estimates last quarter?
Yes. Cadrenal Therapeutics, Inc. Common Stock reported EPS of -$1.14 for the quarter ended Jun 30, 2026, above the -$1.16 estimate, a 1.72% surprise.
What EPS do analysts expect from CVKD next quarter?
The consensus EPS estimate for Cadrenal Therapeutics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.88 from 5 analysts.
How often does CVKD beat earnings estimates?
Cadrenal Therapeutics, Inc. Common Stock beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -5.60%.
CVKD pages: Overview, Earnings, Forecast, Competitors